Award recognizes Von Hoff's contributions to cancer treatment research

March 21, 2000


Dr. Daniel D. Von Hoff, director of the Arizona Cancer Center, is the recipient of the 2000 Jeffrey A. Gottlieb Memorial Award. The award, given annually by the University of Texas M.D. Anderson Cancer Center in Houston, recognizes physicians and scientists who have made contributions to cancer therapeutic research.

Von Hoff was given the award during the "Third Foundations of Clinical Cancer Research Symposium" on March 17, at The University of Texas M.D. Anderson Cancer Center in Houston. Von Hoff also presented an award lecture titled "The Telomere Maintenance Mechanism as a Therapeutic Target." His presentation highlighted his own research into telomerase, an enzyme that is expressed in cancer cells and not in most normal, healthy cell. Telomerase provides s a unique target for cancer drug development.

The Gottlieb Award was established in 1975 to perpetuate the memory of Dr. Jeffrey A. Gottlieb, who himself made outstanding advances in the field of chemotherapy before losing a personal battle to cancer in 1975 at the age of 35.
Past recipients include the late Dr. Sydney E. Salmon, founding director of the Arizona Cancer Center; Dr. Evan M. Hersh, director of experimental therapeutics at the Arizona Cancer Center; and Dr. Vincent DeVita Jr. and Dr. Samuel Broder, former directors of the National Cancer Institute.

Share

Resources for the media